Knockdown of MALAT1 in these breast cancer cells also illustrated a decrease in cell proliferation, suggesting that high E2 doses reduced proliferation of breast cancer cells (ER-α) via reducing the expression of MALAT1 [55]. Here, ESR1 is linked to breast cancer.